Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Cello Health Plc LSE:CLL London Ordinary Share GB00B0310763 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 161.00 160.00 162.00 161.00 160.50 161.00 85,553 08:00:13
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Media 166.8 7.1 -0.9 - 172

Cello Health PLC Form 8 (OPD) - Cello Health plc

02/07/2020 7:00am

UK Regulatory (RNS & others)


Cello Health (LSE:CLL)
Historical Stock Chart


From Jun 2020 to Aug 2020

Click Here for more Cello Health Charts.

TIDMCLL TIDMCLL

RNS Number : 7816R

Cello Health PLC

02 July 2020

FORM 8 (OPD)

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

   1.         KEY INFORMATION 
 
 (a) Full name of discloser:                                                                    Cello Health plc 
 (b) Owner or controller of interests and short positions disclosed, if different from 1(a):    Mark Scott 
  The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), 
  settlor and beneficiaries must be named.                                                       Mark Bentley 
 
                                                                                                 Stephen Highley 
 
                                                                                                 Julia Ralston 
 
                                                                                                 Chris Jones 
 
                                                                                                 Clifford Tompsett 
                                                                                               ------------------- 
 (c) Name of offeror/offeree in relation to whose relevant securities this form relates:        Cello Health plc 
  Use a separate form for each offeror/offeree 
                                                                                               ------------------- 
 (d) Is the discloser the offeror or the offeree?                                               OFFEREE 
                                                                                               ------------------- 
 (e) Date position held:                                                                        30 June 2020 
  The latest practicable date prior to the disclosure 
                                                                                               ------------------- 
 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect   NO 
  of any other party to the offer? 
  If it is a cash offer or possible cash offer, state "N/A" 
                                                                                               ------------------- 
 
   2.         POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 
 Class of relevant security:                                                     ordinary shares of 10 pence each 
                                                                                   Interests          Short positions 
                                                                            ----------------------  ------------------ 
                                                                                Number        %         Number      % 
                                                                            -------------  -------  -------------  --- 
 (1) Relevant securities owned and/or controlled:                              453,000       0.42        NIL        - 
                                                                            -------------  -------  -------------  --- 
 (2) Cash-settled derivatives:                                                   NIL          -          NIL        - 
                                                                            -------------  -------  -------------  --- 
 (3) Stock-settled derivatives (including options) and agreements to             NIL          -          NIL        - 
 purchase/sell: 
                                                                            -------------  -------  -------------  --- 
 
   TOTAL:                                                                      453,000       0.42        NIL        - 
                                                                            -------------  -------  -------------  --- 
 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

   (b)        Rights to subscribe for new securities 
 
 Class of relevant security in relation to which subscription right exists: 
 Details, including nature of the rights concerned and relevant percentages: 
 
 
   3.         POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE 
 
 Details of any interests, short positions and rights to subscribe (including directors' and 
  other employee options) of any person acting in concert with the party to the offer making 
  the disclosure: 
   Director             Number of Offeree   Number of Options 
                          Shares              held in Offeree 
    Mark Scott           1,649,975           701,250 
    Mark Bentley         532,718*            355,000 
    Stephen Highley      2,226,304           370,000 
    Julia Ralston        580,405             560,500 
    Chris Jones          22,726              NIL 
    Clifford Tompsett    20,000              NIL 
 
 
   *includes 60,000 ordinary shares held by persons closely associated with Mark Bentley 
 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

   4.         OTHER INFORMATION 
   (a)        Indemnity and other dealing arrangements 
 
 Details of any indemnity or option arrangement, or any agreement or understanding, formal 
  or informal, relating to relevant securities which may be an inducement to deal or refrain 
  from dealing entered into by the party to the offer making the disclosure or any person acting 
  in concert with it: 
  Irrevocable commitments and letters of intent should not be included. If there are no such 
  agreements, arrangements or understandings, state "none" 
 
 
   (b)        Agreements, arrangements or understandings relating to options or derivatives 
 
 Details of any agreement, arrangement or understanding, formal or informal, between the party 
  to the offer making the disclosure, or any person acting in concert with it, and any other 
  person relating to: 
  (i) the voting rights of any relevant securities under any option; or 
  (ii) the voting rights or future acquisition or disposal of any relevant securities to which 
  any derivative is referenced: 
  If there are no such agreements, arrangements or understandings, state "none" 
 
 
   (c)        Attachments 

Are any Supplemental Forms attached?

 
 Supplemental Form 8 (Open Positions)   NO 
 Supplemental Form 8 (SBL)              NO 
                                       --- 
 
 
 Date of disclosure:    1 July 2020 
 Contact name:          Mark Bentley 
                       -------------------- 
 Telephone number:      +44 (0)20 7812 8463 
                       -------------------- 
 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

FEEMZGGNLMKGGZM

(END) Dow Jones Newswires

July 02, 2020 02:00 ET (06:00 GMT)

1 Year Cello Health Chart

1 Year Cello Health Chart

1 Month Cello Health Chart

1 Month Cello Health Chart
ADVFN Advertorial
Your Recent History
LSE
CLL
Cello Heal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200809 07:44:17